4.4 Article

Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Pathophysiology of Huntingtonʼs disease: from huntingtin functions to potential treatments

Emmanuel Roze et al.

CURRENT OPINION IN NEUROLOGY (2009)

Review Clinical Neurology

A study of chorea after tetrabenazine withdrawal in patients with Huntington disease

Samuel Frank et al.

CLINICAL NEUROPHARMACOLOGY (2008)

Review Clinical Neurology

The Long-term Effect of Tetrabenazine in the Management of Huntington Disease

Alfonso Fasano et al.

CLINICAL NEUROPHARMACOLOGY (2008)

Review Clinical Neurology

The current clinical management of Huntington's disease

Wendy Phillips et al.

MOVEMENT DISORDERS (2008)

Review Clinical Neurology

Symptomatic treatment of Huntington disease

Octavian R. Adam et al.

NEUROTHERAPEUTICS (2008)

Article Neurosciences

Dopaminergic signaling and striatal neurodegeneration in Huntington's disease

Tie-Shan Tang et al.

JOURNAL OF NEUROSCIENCE (2007)

Article Clinical Neurology

Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders

Christopher Kenney et al.

MOVEMENT DISORDERS (2007)

Article Clinical Neurology

Short-term effects of tetrabenazine on chorea associated with Huntington's disease

Christopher Kenney et al.

MOVEMENT DISORDERS (2007)

Review Pharmacology & Pharmacy

Pharmacological management of Huntington's disease: An evidence-based review

Raphael M. Bonelli et al.

CURRENT PHARMACEUTICAL DESIGN (2006)

Review Clinical Neurology

Is history of depression a contraindication to treatment with tetrabenazine?

Christopher Kenney et al.

CLINICAL NEUROPHARMACOLOGY (2006)

Article Psychiatry

Critical periods of suicide risk in Huntington's disease

JS Paulsen et al.

AMERICAN JOURNAL OF PSYCHIATRY (2005)

Review Clinical Neurology

Tetrabenazine treatment for Huntington's disease - Associated chorea

WG Ondo et al.

CLINICAL NEUROPHARMACOLOGY (2002)